Integrated analysis of genome-wide copy number variation and exome-wide rare variation identified novel loci for rheumatoid arthritis
Authors' conclusion
This study provides valuable insights into deciphering the genetic basis of RA and offers potential precision medicine strategies for RA.
Study context
- Population
- UK Biobank participants (RA); synovial tissue gene expression profiles of RA patients and healthy controls
- Outcome
- Genetic loci associated with RA
Methodological detailsgenome-wide copy number variations (CNV) association study, exome-wide rare variation gene-based burden test, integrated analysis, UK Biobank
- Genome-wide CNV association study
- Exome-wide rare variation gene-based burden test
- Integrated analysis
- UK Biobank
Main finding
As reported in the abstract
Significant CNV signals (genome-wide CNV association study, covariate-adjusted)
92
Genome-wide significant associations (gene-based burden test of exonic variants)
94
Common loci from integrated CNV and exome-wide rare variation analysis (e.g. GPER1)
3
Genes overlapping between CNV findings and gene expression profiles (e.g. HLA-DQB1)
2
Further findings
Drug repurposing (Drug-Gene Interaction Database)
- Novel pharmacological agents identified that could modulate the activity of the common genes
Original publication
Integrated analysis of genome-wide copy number variation and exome-wide rare variation identified novel loci for rheumatoid arthritis. Clin Exp Rheumatol. Published 21 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →